Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p61
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 61/66)
Character Range: 200688–205950

grade 1 or 2; AND
                                                      The treatment must be the sole PBS-subsidised therapy for this condition;
                                                      Patient must be at least 18 years of age.
                                                      WHO grade 1 of GEP-NET is defined as a mitotic count (10HPF) of less than 2 and Ki-67 index (%) of less than or equal to 2.
                                                      WHO grade 2 of GEP-NET is defined as a mitotic count (10HPF) of 2-20 and Ki-67 index (%) of 3-20.
C16141  P16141  CN16141  Fluconazole                  Cryptococcal meningitis                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 16141
                                                      Patient must be unable to take a solid dose form of fluconazole; AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16145  P16145  CN16145  Chlormethine                 Mycosis fungoides cutaneous T-cell lymphoma                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures
                                                      Initial treatment
                                                      The condition must be any of: (i) Stage IA, (ii) IIA, (iii) IB mycosis fungoides cutaneous T-cell lymphoma; AND
                                                      The condition must have been confirmed through a diagnostic lesion biopsy from an Approved Pathology Authority; AND
                                                      The condition must cover either of which: (i) no more than 10% of the patient's body surface area, (ii) no more than 25% of the patient's body surface area; AND
                                                      Patient must be treated by at least one of the following prescriber types (i) dermatologist, (ii) haematologist; AND
                                                      The treatment must be approved for 1 unit if the condition is no more than 10% of the patient's body surface area to provide 4 weeks of treatment per script; or
                                                      The treatment must be approved for 2 units if the condition is no more than 25% of the patient's body surface area to provide 4 weeks of treatment per script;
                                                      Patient must be at least 18 years of age.
                                                      Confirmation of eligibility for treatment with diagnostic reports must be documented in the patient's medical records.
C16147  P16147  CN16147  Tirofiban                    High risk of unstable angina                                                                                                                                                                                                                                                                                                                                                                                        Compliance with Authority Required procedures - Streamlined Authority Code 16147
                                                      Patient must have new transient or persistent ST-T ischaemic changes; AND
                                                      Patient must have repetitive episodes of angina at rest or during minimal exercise in the previous 12 hours; AND
                                                      Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.
C16148  P16148  CN16148  Fluconazole                  Cryptococcal meningitis                                                                                                                                                                                                                                                                                                                                                                                             Compliance with